The Role of Biomimetic Platforms

Understanding lung cancer bone metastasis is crucial for developing effective therapies. Organ-on-a-chip systems provide invaluable insights by simulating the physiological conditions of human organs. Furthermore, researchers have now applied a leaf vein microfluidic chip to investigate tumor cell behavior within a bone-mimetic environment. Specifically, the hierarchical architecture of leaf veins resembles mammalian blood vessels, allowing for precise studies of spatial cell distribution.

Investigating Lung Cancer Bone Metastasis Mechanisms

The system incorporates specialized chambers that house 3D hydrogels containing human umbilical vein endothelial cells and bone stromal cells. These chambers effectively create a dormancy niche where cancer cells may persist. Additionally, the platform simulates a "vicious cycle niche" to examine aggressive tumor invasion. Consequently, researchers can observe how the bone microenvironment responds to factors secreted by primary tumor cells during the pre-metastatic phase.

Notably, the study identified several biomarkers associated with disease progression. In the dormancy niche, the upregulation of angiogenin and Wnt-5a suggests that tumor factors can reactivate quiet cells. Moreover, the vicious cycle niche showed increased levels of CCL5 and CXCL5, which promote leukocyte recruitment and tumor spread. Therefore, these cytokines serve as promising targets for new therapies. This leaf vein chip establishes a versatile platform for future drug screening and pathological analysis.

Frequently Asked Questions

What is a bone-on-leaf-chip?

A bone-on-leaf-chip is a microfluidic device that uses the natural branching pattern of leaf veins to mimic the structure of human blood vessels for medical research.

How does the dormancy niche affect lung cancer?

The dormancy niche is a specialized microenvironment where tumor cells remain inactive. Secreted factors like angiogenin can reactivate these cells, leading to active metastasis.

Can this platform be used for drug testing?

Yes, the chip provides a mechanistically tractable platform for screening new drugs and evaluating targeted therapies against bone metastasis.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Liu Q et al. Bone-on-leaf-chip for the study of lung cancer bone metastasis. Lab Chip. 2026 Feb 18. doi: 10.1039/d5lc00951k. PMID: 41706526.

Munoz Castro N, et al. Multi-omics qualification of an organ-on-a-chip model of osteolytic bone metastasis. Bioengineering & Translational Medicine. 2025;10(1):e10612.

Liu T, et al. Premetastatic Niche Mimicking Bone-On-A-Chip: A Microfluidic Platform to Study Bone Metastasis in Cancer Patients. Small. 2023 Dec;19(49):e2207606.